Skip to content

Melissa Officinalis L. Supplementation for Emotional Health and Sleep Disturbance

Study to Investigate Melissa Officinalis L. Supplementation for Emotional Health and Sleep Disturbance: A Perspective, Randomized, Double-blinded, Placebo-controlled, Parallel-group Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05602688
Enrollment
102
Registered
2022-11-02
Start date
2023-01-03
Completion date
2023-04-30
Last updated
2023-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Insomnia, Stress

Brief summary

This study is aimed to investigate if Lemon Balm Extract supplementation is beneficial for the relief of stress, depression and anxiety in healthy adults.

Detailed description

Lemon balm (Botanical name: Melissa officinalis L.) is a herbal plant belongs to the Lamiaceae (mint) family, and currently of wide scientific interest as possible adjuvant for calming effect. Lemon balm is one of the most popular and widely used medicinal herbs in central and southern Europe, the Mediterranean region, and west Asia. The European Scientific Cooperative on Phytotherapy (ESCOP) recommends the use of lemon balm to relieve of mild symptoms of anxiety, including mental stress, restlessness, and irritability. Historically, Lemon balm has been widely used in Asian traditional medicine as a sedative to treat many psychiatric disorders, such as stress, depression, anxiety, and insomnia. Lemon balm has shown anti-depressant, anxiolytic, and anti-insomnia effects both in human clinical trials and in animal model studies.

Interventions

DIETARY_SUPPLEMENTLemon Balm Supplement

Oral 200 mg Lemon Balm supplement tablet Twice a day for three-weeks

DIETARY_SUPPLEMENTMatched Placebo

Matched placebo tablet Twice a day for three-weeks

Sponsors

Ayub Teaching Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy individuals, aged 18 - 65 years * Individuals suffering from moderate degree of depression, anxiety, and stress with DASS scores ≥14, ≥10, and ≥19, respectively, or individual with sleep problems with Pittsburgh Sleep Quality Index (PSQI) score ≥5. * Willing to participate in the study

Exclusion criteria

* Current use of prescribed medication or supplements for neuropsychiatric and sleep disorders * Known history of neuropsychiatric or sleep disorders * Current use or history of illicit substances misuse * History of any allergic reactions to ingredients of the Lemon Balm Extract * Hypertension (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90, or other cardiovascular disease * Hyperthyroidism or Diabetes mellitus or cancer * Use of blood thinners like Coumadin (warfarin) or Plavix (clopidogrel), Glaucoma medications like Travatan (travoprost), Chemotherapy drugs like tamoxifen and Camptosar (irinotecan) * Severe medical problem, which in the opinion of the investigator would pose a safety risk to the subject

Design outcomes

Primary

MeasureTime frameDescription
Changes in the level of depression3 weeksImprovement in the Depression score in the Depression Anxiety and Stress Scale (DASS)
Changes in the level of anxiety3 weeksImprovement in the Anxiety score in the Depression Anxiety and Stress Scale (DASS)
Changes in the level of stress3 weeksImprovement in the Stress score in the Depression Anxiety and Stress Scale (DASS)
Changes in sleep quality3 weeksImprovement in the Pittsburgh Sleep Quality Index (PSQI) scale score

Secondary

MeasureTime frameDescription
Changes in Positive and Negative Emotional Feelings3 weeksImprovement in the Positive and Negative Affect Scale (PANAS) score
Changes in the Quality of Life (QoL)3 weeksImprovement in the WHO QOL-BREF scale scores
Changes in mental wellbeing3 weeksImprovement in the Warwick Edinburgh Mental Wellbeing Scale (WEMWBS) score

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026